NCT04064112 (SCCIXT) is a NA clinical trial of S-BLR in Convergence Insufficiency Intermittent Exotropia (CI-IXT), sponsored by Chen Zhao.

Who is sponsoring NCT04064112?

NCT04064112 is sponsored by Chen Zhao.

What drugs are being tested in NCT04064112?

Interventions in NCT04064112: S-BLR, C-BLR.

What condition does NCT04064112 study?

NCT04064112 studies Convergence Insufficiency Intermittent Exotropia (CI-IXT).

Is NCT04064112 still recruiting?

NCT04064112 is currently completed. Last updated 20 December 2023.

Last reviewed 2023-12-20 · How we verify

NCT04064112: SCCIXT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

S-BLR Versus C-BLR for CI-IXT in Children

Completed NA Last updated 20 December 2023

What this trial tests

NA trial testing S-BLR in Convergence Insufficiency Intermittent Exotropia (CI-IXT) in 200 participants. Completed in 11 February 2023.

Timeline

18 October 2019

Primary endpoint
19 February 2022

11 February 2023

Quick facts

Lead sponsor	Chen Zhao
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	18 October 2019
Primary completion	19 February 2022
Estimated completion	11 February 2023
Sites	1 location across China

Drugs / interventions tested

S-BLR
C-BLR

Conditions studied

Convergence Insufficiency Intermittent Exotropia (CI-IXT) — all drugs for Convergence Insufficiency Intermittent Exotropia (CI-IXT) →

Sponsor

Chen Zhao

Who can join

Adults 5 to 12, any sex, with Convergence Insufficiency Intermittent Exotropia (CI-IXT). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-center, randomized single-blind controlled trial to compare the effectiveness of S-BLR with C-BLR for the treatment of CI-IXT in children. Specific Aim 1 (Primary): To compare the surgical successful rate of S-BLR with C-BLR for the treatment of CI-IXT in children. Specific Aim 2 (Secondary): To study the suboptimal surgical outcomes between S-BLR and C-BLR for the treatment of CI-IXT in children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04064112 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chen Zhao
Last refreshed: 20 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04064112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing